세계의 혈관색전술 시장 규모 조사 및 예측 : 제품별, 용도별, 최종사용자별, 지역별 분석(2022-2029년)

Global Vascular Embolization Market is valued at approximately USD 3.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2022-2029. Embolization is a minimally invasive treatment that blocks one or more blood vessels or abnormal vascular channels. And provide temporary or permanent relief of the condition by removing atypical blood vessel connections. The increasing prevalence of vascular diseases is anticipated to boost the Vascular Embolization Market throughout the forecast period of 2022-2029.

The increasing prevalence of vascular diseases and minimally invasive vascular procedures is one of the primary reasons for the growth of the Vascular Embolization Market. According to the World Health Organization, in 2020, 17.9 million people died from cardiovascular diseases worldwide. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. For instance, according to the article published in Cureus Journal of Medical Science in July 2020, ischemic heart disease affects around 1,655 per 100,000 and is expected to exceed 1,845 per 1,00,000 by 2030. Also, various new product launches by key players and increased investments by governments of various countries to improve healthcare infrastructure are anticipated demands in the forecast period. Moreover, technological advancements in embolization products and increasing research and development activities are the key driving factors in the global Vascular Embolization Market. However, the high cost associated with the procedures stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Vascular Embolization Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to increasing research and development activities, increased vascular related diseases such as Cancer and brain aneurysm and increased research and development activities. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising chronic diseases, surge in healthcare expenditure and growing awareness about vascular embolization, changing lifestyle, and increasing population in this region.

Major market player included in this report are:

• Medtronic PLC
• Cook Medical
• Stryker Corporation
• Boston Scientific Corporation
• Abbott Laboratories
• Johnson and Johnson (CERENOVUS) Private Limited,
• Merit Medical Systems Inc.
• Penumbra Inc.
• Terumo Medical Corporation
• Shape Memory Medical Inc.

Recent Developments in the Market:

In July 2021, Terumo Medical Corporation (TMC)released the AZUR Vascular Plug, the first plug compatible with a microcatheter.This can be used to slow or stop blood flow in arteries of the peripheral vasculature.

In April 2021, the US Food and Drug Administration (FDA) approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was indicated primarily for brain aneurysms. Shield Technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.

Global Vascular Embolization Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Product, Application, End User, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Embolic Agents
• Embolization Devices

By Application:

• Oncology
• Peripheral Vascular Diseases
• Urology and Nephrology
• Neurology
• Others

By End user:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Vascular Embolization Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Vascular Embolization Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Vascular Embolization Market, by Application, 2019-2029 (USD Billion)
  • 1.2.4. Vascular Embolization Market, by End User, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Vascular Embolization Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Vascular Embolization Market Dynamics

• 3.1. Vascular Embolization Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing Prevalence of Vascular Diseases
    • 3.1.1.2. Increased investments by governments in healthcare
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Costs Associated with Embolization Procedures
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing technological advancements in embolization products
    • 3.1.3.2. Increasing Research and Development Activities

Chapter 4. Global Vascular Embolization Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Vascular Embolization Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Vascular Embolization Market by Product, Performance - Potential Analysis
• 6.3. Global Vascular Embolization Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 6.4. Vascular Embolization Market, Sub Segment Analysis
  • 6.4.1.1. Embolic Agents
  • 6.4.1.2. Embolization Devices

Chapter 7. Global Vascular Embolization Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Vascular Embolization Market by Application, Performance - Potential Analysis
• 7.3. Global Vascular Embolization Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Vascular Embolization Market, Sub Segment Analysis
  • 7.4.1. Oncology
  • 7.4.2. Peripheral Vascular Diseases
  • 7.4.3. Urology and Nephrology
  • 7.4.4. Neurology
  • 7.4.5. Other

Chapter 8. Global Vascular Embolization Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Vascular Embolization Market by End User, Performance - Potential Analysis
• 8.3. Global Vascular Embolization Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 8.4. Vascular Embolization Market, Sub Segment Analysis
  • 8.4.1. Hospitals and Clinics
  • 8.4.2. Ambulatory Surgical Centers
  • 8.4.3. Others

Chapter 9. Global Vascular Embolization Market, Regional Analysis

• 9.1. Vascular Embolization Market, Regional Market Snapshot
• 9.2. North America Vascular Embolization Market
  • 9.2.1. U.S. Vascular Embolization Market
    • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Vascular Embolization Market
• 9.3. Europe Vascular Embolization Market Snapshot
  • 9.3.1. U.K. Vascular Embolization Market
  • 9.3.2. Germany Vascular Embolization Market
  • 9.3.3. France Vascular Embolization Market
  • 9.3.4. Spain Vascular Embolization Market
  • 9.3.5. Italy Vascular Embolization Market
  • 9.3.6. Rest of Europe Vascular Embolization Market
• 9.4. Asia-Pacific Vascular Embolization Market Snapshot
  • 9.4.1. China Vascular Embolization Market
  • 9.4.2. India Vascular Embolization Market
  • 9.4.3. Japan Vascular Embolization Market
  • 9.4.4. Australia Vascular Embolization Market
  • 9.4.5. South Korea Vascular Embolization Market
  • 9.4.6. Rest of Asia Pacific Vascular Embolization Market
• 9.5. Latin America Vascular Embolization Market Snapshot
  • 9.5.1. Brazil Vascular Embolization Market
  • 9.5.2. Mexico Vascular Embolization Market
• 9.6. Rest of The World Vascular Embolization Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Medtronic PLC
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Cook Medical
  • 10.2.3. Stryker Corporation
  • 10.2.4. Boston Scientific Corporation
  • 10.2.5. Abbott Laboratories
  • 10.2.6. Johnson and Johnson (CERENOVUS) Private Limited,
  • 10.2.7. Merit Medical Systems Inc.
  • 10.2.8. Penumbra Inc.
  • 10.2.9. Terumo Medical Corporation

10.2.10 Shape Memory Medical Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption